These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25555173)

  • 41. Loteprednol Etabonate 0.5%/Tobramycin 0.3% Compared with Dexamethasone 0.1%/Tobramycin 0.3% for the Treatment of Blepharitis.
    Comstock TL; DeCory HH
    Ocul Immunol Inflamm; 2017 Apr; 25(2):267-274. PubMed ID: 26788833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular Surgery.
    Kang C; Keam SJ; Shirley M; Syed YY
    Clin Drug Investig; 2020 Apr; 40(4):387-394. PubMed ID: 32172521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Double-masked study of the effects of nepafenac 0.1% and ketorolac 0.4% on corneal epithelial wound healing and pain after photorefractive keratectomy.
    Donnenfeld ED; Holland EJ; Durrie DS; Raizman MB
    Adv Ther; 2007; 24(4):852-62. PubMed ID: 17901034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective, contralateral eye study comparing thin-flap LASIK (sub-Bowman keratomileusis) with photorefractive keratectomy.
    Slade SG; Durrie DS; Binder PS
    Ophthalmology; 2009 Jun; 116(6):1075-82. PubMed ID: 19486798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corneal power, thickness, and stiffness: results of a prospective randomized controlled trial of PRK and LASIK for myopia.
    Hjortdal JØ; Møller-Pedersen T; Ivarsen A; Ehlers N
    J Cataract Refract Surg; 2005 Jan; 31(1):21-9. PubMed ID: 15721693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis. The Loteprednol Etabonate Giant Papillary Conjunctivitis Study Group I.
    Friedlaender MH; Howes J
    Am J Ophthalmol; 1997 Apr; 123(4):455-64. PubMed ID: 9124242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tolerability of loteprednol/tobramycin versus dexamethasone/tobramycin in healthy volunteers: results of a 4-week, randomized, double-masked, parallel-group study.
    Bartlett JD; Holland EJ; Usner DW; Paterno MR; Comstock TL
    Curr Med Res Opin; 2008 Aug; 24(8):2219-27. PubMed ID: 18577309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective Randomized Trial Comparing Efficacy of Topical Loteprednol Etabonate 0.5% Versus Cyclosporine-A 0.05% for Treatment of Dry Eye Syndrome Following Hematopoietic Stem Cell Transplantation.
    Boynton GE; Raoof D; Niziol LM; Hussain M; Mian SI
    Cornea; 2015 Jul; 34(7):725-32. PubMed ID: 25850708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Efficacy of Difluprednate 0.05% and Loteprednol Gel 0.5% After Cataract Surgery.
    Abessi B; Brooksby L; Schultze RL
    Eye Contact Lens; 2018 Nov; 44 Suppl 2():S37-S42. PubMed ID: 28628490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toric intraocular lens versus monofocal intraocular lens implantation and photorefractive keratectomy: a randomized controlled trial.
    Nagpal R; Sharma N; Vasavada V; Maharana PK; Titiyal JS; Sinha R; Upadhyay AD; Vajpayee RB
    Am J Ophthalmol; 2015 Sep; 160(3):479-486.e2. PubMed ID: 26095261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of postoperative pain in patients following photorefractive keratectomy versus advanced surface ablation.
    Blake CR; Cervantes-Castañeda RA; Macias-Rodríguez Y; Anzoulatous G; Anderson R; Chayet AS
    J Cataract Refract Surg; 2005 Jul; 31(7):1314-9. PubMed ID: 16105600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Past and present of corneal refractive surgery: a retrospective study of long-term results after photorefractive keratectomy and a prospective study of refractive lenticule extraction.
    Vestergaard AH
    Acta Ophthalmol; 2014 Mar; 92 Thesis 2():1-21. PubMed ID: 24636364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and tolerability of loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension in pediatric subjects.
    Comstock TL; Paterno MR; Bateman KM; Decory HH; Gearinger M
    Paediatr Drugs; 2012 Apr; 14(2):119-30. PubMed ID: 22292487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery.
    Fong R; Silverstein BE; Peace JH; Williams JI; Vittitow JL
    J Cataract Refract Surg; 2018 Oct; 44(10):1220-1229. PubMed ID: 30193927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of intraocular pressure elevating activity of loteprednol etabonate and dexamethasone in rabbits.
    Bodor N; Bodor N; Wu WM
    Curr Eye Res; 1992 Jun; 11(6):525-30. PubMed ID: 1505197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aspheric versus wavefront-guided photorefractive keratectomy: contralateral eye study.
    Zarei-Ghanavati S; Gharaee H; Hamilton DR; Sanchez PJ; Abrishami M
    J Cataract Refract Surg; 2015 Jul; 41(7):1441-7. PubMed ID: 26287882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transepithelial photorefractive keratectomy: clinical results.
    Fadlallah A; Fahed D; Khalil K; Dunia I; Menassa J; El Rami H; Chlela E; Fahed S
    J Cataract Refract Surg; 2011 Oct; 37(10):1852-7. PubMed ID: 21840678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparison of laser subepithelial keratomileusis and photorefractive keratectomy for the correction of myopia].
    He TG; Wang LJ; Sun ZY; Shi XR
    Zhonghua Yan Ke Za Zhi; 2004 Sep; 40(9):579-82. PubMed ID: 15500759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compare the effects of two silicone-hydrogel bandage contact lenses on epithelial healing after photorefractive keratectomy with anterior segment optical coherence tomography.
    Eliaçık M; Erdur SK; Gülkılık G; Özsütçü M; Karabela Y
    Cont Lens Anterior Eye; 2015 Jun; 38(3):215-9. PubMed ID: 25707929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intraocular pressure response to loteprednol etabonate in known steroid responders.
    Bartlett JD; Horwitz B; Laibovitz R; Howes JF
    J Ocul Pharmacol; 1993; 9(2):157-65. PubMed ID: 8345288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.